A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

NCT03703570 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

502

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: KW-6356
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.